Filter by: Subject

Filter by: Subject

Results Per Page:

Human immunodeficiency virus (HIV) (17)
South Africa (SA) (4)
Sub-Saharan Africa (SSA) (4)
Adolescent girls and young women (AGYW) (3)
Pre-exposure prophylaxis (PrEP) (3)
SDG-03: Good health and well-being (3)
Sexually transmitted infection (STI) (3)
Antiretroviral therapy (ART) (2)
Chlamydia trachomatis (CT) (2)
Diagnosis (2)
HIV infection (2)
HIV prevention (2)
Management (2)
Pregnant women (2)
Tuberculosis (TB) (2)
Women (2)
Anti-tuberculous treatment (ATT) (1)
ART initiation (1)
Bacterial vaginosis (1)
Challenges (1)
Children (1)
Clinical trials (1)
Community health worker (CHW) (1)
Complications (1)
Comprehensive HIV knowledge (1)
Computed tomography (1)
Death (1)
Delayed ART initiation (1)
Demographic and health survey (1)
Diagnostics (1)
Discrete choice experiment (1)
End-of-treatment (1)
Ethiopia (1)
Evidence for contraceptive options and HIV outcomes (ECHO) (1)
Eye (1)
Female genital tract (1)
Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) (1)
Genital tract infection (1)
Gonorrhoea (1)
Gonorrhoea (Neisseria gonorrhoeae) (1)
Health clinics (1)
Highly active antiretroviral therapy (HAART) (1)
HIV infections (1)
HIV-TB coinfection (1)
Implant (1)
Infection (1)
LGV biovar (1)
Lipoarabinomannan (LAM) (1)
Low- and middle-income countries (LMICs) (1)
Lymphogranuloma venereum (LGV) (1)
MPT64 (1)
Multilevel factors (1)
Mycobacterial antigens (1)
Neisseria gonorrhoeae (NG) (1)
Nerve fiber layer (1)
Ocular disease (1)
Ocular syphilis (1)
Opportunistic infection (1)
People living with HIV (PLWHIV) (1)
Pleural fluid mononuclear cells (1)
Pleural fluid mononuclear cells (PFMC) (1)
Pleural tuberculosis (1)
Pregnancy (1)
PrEP access (1)
PrEP initiation (1)
PrEP uptake (1)
Preterm birth (1)
Prevention (1)
Primary healthcare (1)
Pulmonary tuberculosis (1)
Residence (1)
Residual metabolic activity (RMA) (1)
Retention in care (1)
Retinopathy (1)
Routine data (1)
Screening (1)
South Africa (1)
Stepped wedge (1)
Stigma (1)
Syphilis (1)
Technical assistance (1)
Trichomonas vaginalis (TV) (1)
Vaccine (1)
Vaccine-induced seropositivity (VISP) (1)
Vaginal inflammation (1)
Vaginal metabolome (1)
Vaginal microbiome (1)
Ward-based outreach teams (WBOTs) (1)
Women living with HIV (WLHIV) (1)
Young women (1)